vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and 1ST SOURCE CORP (SRCE). Click either name above to swap in a different company.

1ST SOURCE CORP is the larger business by last-quarter revenue ($113.1M vs $61.5M, roughly 1.8× Axogen, Inc.). 1ST SOURCE CORP runs the higher net margin — 35.3% vs -31.9%, a 67.2% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs 8.7%). 1ST SOURCE CORP produced more free cash flow last quarter ($58.1M vs $-1.4M). Over the past eight quarters, Axogen, Inc.'s revenue compounded faster (13.3% CAGR vs 7.8%).

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

1st Source Corporation is a financial services company headquartered in South Bend, Indiana. It operates 1st Source Bank, a bank with 81 branches in Indiana and Michigan. The bank's Specialty Finance Group provides financing for aircraft, trucks, and construction equipment. 1st Source Insurance provides insurance products and services.

AXGN vs SRCE — Head-to-Head

Bigger by revenue
SRCE
SRCE
1.8× larger
SRCE
$113.1M
$61.5M
AXGN
Growing faster (revenue YoY)
AXGN
AXGN
+17.8% gap
AXGN
26.6%
8.7%
SRCE
Higher net margin
SRCE
SRCE
67.2% more per $
SRCE
35.3%
-31.9%
AXGN
More free cash flow
SRCE
SRCE
$59.5M more FCF
SRCE
$58.1M
$-1.4M
AXGN
Faster 2-yr revenue CAGR
AXGN
AXGN
Annualised
AXGN
13.3%
7.8%
SRCE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AXGN
AXGN
SRCE
SRCE
Revenue
$61.5M
$113.1M
Net Profit
$-19.6M
$40.0M
Gross Margin
75.2%
Operating Margin
20.2%
45.4%
Net Margin
-31.9%
35.3%
Revenue YoY
26.6%
8.7%
Net Profit YoY
-410.8%
6.5%
EPS (diluted)
$-0.38
$1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
SRCE
SRCE
Q1 26
$61.5M
$113.1M
Q4 25
$59.9M
$110.8M
Q3 25
$60.1M
$110.7M
Q2 25
$56.7M
$108.2M
Q1 25
$48.6M
$104.0M
Q4 24
$49.4M
$97.8M
Q3 24
$48.6M
$97.9M
Q2 24
$47.9M
$97.3M
Net Profit
AXGN
AXGN
SRCE
SRCE
Q1 26
$-19.6M
$40.0M
Q4 25
$-13.2M
$41.1M
Q3 25
$708.0K
$42.3M
Q2 25
$579.0K
$37.3M
Q1 25
$-3.8M
$37.5M
Q4 24
$450.0K
$31.4M
Q3 24
$-1.9M
$34.9M
Q2 24
$-1.9M
$36.8M
Gross Margin
AXGN
AXGN
SRCE
SRCE
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
Operating Margin
AXGN
AXGN
SRCE
SRCE
Q1 26
20.2%
45.4%
Q4 25
-16.3%
Q3 25
3.2%
49.7%
Q2 25
3.0%
44.5%
Q1 25
-3.4%
45.8%
Q4 24
4.1%
Q3 24
-0.6%
46.3%
Q2 24
-0.9%
49.1%
Net Margin
AXGN
AXGN
SRCE
SRCE
Q1 26
-31.9%
35.3%
Q4 25
-22.0%
37.1%
Q3 25
1.2%
38.2%
Q2 25
1.0%
34.5%
Q1 25
-7.9%
36.1%
Q4 24
0.9%
32.1%
Q3 24
-3.8%
35.7%
Q2 24
-4.0%
37.8%
EPS (diluted)
AXGN
AXGN
SRCE
SRCE
Q1 26
$-0.38
$1.63
Q4 25
$-0.28
$1.67
Q3 25
$0.01
$1.71
Q2 25
$0.01
$1.51
Q1 25
$-0.08
$1.52
Q4 24
$-0.00
$1.27
Q3 24
$-0.04
$1.41
Q2 24
$-0.04
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
SRCE
SRCE
Cash + ST InvestmentsLiquidity on hand
$82.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$1.3B
Total Assets
$289.5M
$9.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
SRCE
SRCE
Q1 26
$82.7M
Q4 25
$41.5M
Q3 25
$35.8M
Q2 25
$29.9M
Q1 25
$22.1M
Q4 24
$33.5M
Q3 24
$24.5M
Q2 24
$21.1M
Total Debt
AXGN
AXGN
SRCE
SRCE
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AXGN
AXGN
SRCE
SRCE
Q1 26
$244.8M
$1.3B
Q4 25
$128.8M
$1.3B
Q3 25
$120.8M
$1.2B
Q2 25
$112.3M
$1.2B
Q1 25
$105.4M
$1.2B
Q4 24
$103.9M
$1.1B
Q3 24
$99.4M
$1.1B
Q2 24
$95.7M
$1.0B
Total Assets
AXGN
AXGN
SRCE
SRCE
Q1 26
$289.5M
$9.1B
Q4 25
$221.7M
$9.1B
Q3 25
$216.4M
$9.1B
Q2 25
$205.5M
$9.1B
Q1 25
$196.2M
$9.0B
Q4 24
$203.7M
$8.9B
Q3 24
$192.0M
$8.8B
Q2 24
$188.9M
$8.9B
Debt / Equity
AXGN
AXGN
SRCE
SRCE
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
SRCE
SRCE
Operating Cash FlowLast quarter
$59.1M
Free Cash FlowOCF − Capex
$-1.4M
$58.1M
FCF MarginFCF / Revenue
-2.3%
51.4%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.48×
TTM Free Cash FlowTrailing 4 quarters
$9.1M
$361.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
SRCE
SRCE
Q1 26
$59.1M
Q4 25
$3.0M
$223.1M
Q3 25
$3.2M
$51.0M
Q2 25
$7.7M
$44.9M
Q1 25
$-13.2M
$71.8M
Q4 24
$8.7M
$193.9M
Q3 24
$3.9M
$68.4M
Q2 24
$4.2M
$50.0M
Free Cash Flow
AXGN
AXGN
SRCE
SRCE
Q1 26
$-1.4M
$58.1M
Q4 25
$1.8M
$213.0M
Q3 25
$1.7M
$47.3M
Q2 25
$7.0M
$43.0M
Q1 25
$-13.4M
$69.3M
Q4 24
$8.1M
$181.5M
Q3 24
$3.3M
$66.7M
Q2 24
$3.3M
$46.4M
FCF Margin
AXGN
AXGN
SRCE
SRCE
Q1 26
-2.3%
51.4%
Q4 25
3.0%
192.2%
Q3 25
2.8%
42.7%
Q2 25
12.4%
39.8%
Q1 25
-27.7%
66.6%
Q4 24
16.3%
185.5%
Q3 24
6.8%
68.1%
Q2 24
6.8%
47.7%
Capex Intensity
AXGN
AXGN
SRCE
SRCE
Q1 26
0.9%
Q4 25
2.1%
9.1%
Q3 25
2.5%
3.4%
Q2 25
1.3%
1.7%
Q1 25
0.5%
2.4%
Q4 24
1.4%
12.6%
Q3 24
1.2%
1.7%
Q2 24
1.9%
3.7%
Cash Conversion
AXGN
AXGN
SRCE
SRCE
Q1 26
1.48×
Q4 25
5.42×
Q3 25
4.55×
1.21×
Q2 25
13.35×
1.20×
Q1 25
1.91×
Q4 24
19.41×
6.17×
Q3 24
1.96×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons